Suppr超能文献

苯丙醇胺与出血性中风风险

Phenylpropanolamine and the risk of hemorrhagic stroke.

作者信息

Kernan W N, Viscoli C M, Brass L M, Broderick J P, Brott T, Feldmann E, Morgenstern L B, Wilterdink J L, Horwitz R I

机构信息

Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn 06520-8025, USA.

出版信息

N Engl J Med. 2000 Dec 21;343(25):1826-32. doi: 10.1056/NEJM200012213432501.

Abstract

BACKGROUND

Phenylpropanolamine is commonly found in appetite suppressants and cough or cold remedies. Case reports have linked the use of products containing phenylpropanolamine to hemorrhagic stroke, often after the first use of these products. To study the association, we designed a case-control study.

METHODS

Men and women 18 to 49 years of age were recruited from 43 U.S. hospitals. Eligibility criteria included the occurrence of a subarachnoid or intracerebral hemorrhage within 30 days before enrollment and the absence of a previously diagnosed brain lesion. Random-digit dialing identified two matched control subjects per patient.

RESULTS

There were 702 patients and 1376 control subjects. For women, the adjusted odds ratio was 16.58 (95 percent confidence interval, 1.51 to 182.21; P=0.02) for the association between the use of appetite suppressants containing phenylpropanolamine and the risk of a hemorrhagic stroke and 3.13 (95 percent confidence interval, 0.86 to 11.46; P=0.08) for the association with the first use of a product containing phenylpropanolamine. All first uses of phenylpropanolamine involved cough or cold remedies. For men and women combined, the adjusted odds ratio was 1.49 (95 percent confidence interval, 0.84 to 2.64; P=0.17) for the association between the use of a product containing phenylpropanolamine and the risk of a hemorrhagic stroke, 1.23 (95 percent confidence interval, 0.68 to 2.24; P=0.49) for the association with the use of cough or cold remedies that contained phenylpropanolamine, and 15.92 (95 percent confidence interval, 1.38 to 184.13; P=0.03) for the association with the use of appetite suppressants that contained phenylpropanolamine. An analysis in men showed no increased risk of a hemorrhagic stroke in association with the use of cough or cold remedies containing phenylpropanolamine. No men reported the use of appetite suppressants.

CONCLUSIONS

The results suggest that phenylpropanolamine in appetite suppressants, and possibly in cough and cold remedies, is an independent risk factor for hemorrhagic stroke in women.

摘要

背景

苯丙醇胺常见于食欲抑制剂以及止咳或感冒药中。病例报告显示,使用含苯丙醇胺的产品与出血性中风有关,通常在首次使用这些产品后出现。为研究这种关联,我们设计了一项病例对照研究。

方法

从美国43家医院招募18至49岁的男性和女性。入选标准包括在入组前30天内发生蛛网膜下腔或脑出血且此前未诊断出脑部病变。通过随机数字拨号为每位患者确定两名匹配的对照者。

结果

共有702例患者和1376名对照者。对于女性,含苯丙醇胺的食欲抑制剂使用与出血性中风风险之间的关联调整后的优势比为16.58(95%置信区间为1.51至182.21;P = 0.02),首次使用含苯丙醇胺产品的关联调整后的优势比为3.13(95%置信区间为0.86至11.46;P = 0.08)。所有苯丙醇胺的首次使用均涉及止咳或感冒药。对于男性和女性合并分析,含苯丙醇胺产品的使用与出血性中风风险之间的关联调整后的优势比为1.49(95%置信区间为0.84至2.64;P = 0.17),使用含苯丙醇胺的止咳或感冒药的关联调整后的优势比为1.23(95%置信区间为0.68至2.24;P = 0.49),使用含苯丙醇胺的食欲抑制剂的关联调整后的优势比为15.92(95%置信区间为1.38至184.13;P = 0.03)。对男性的分析显示,使用含苯丙醇胺的止咳或感冒药与出血性中风风险增加无关。没有男性报告使用食欲抑制剂。

结论

结果表明,食欲抑制剂中的苯丙醇胺,可能还有止咳和感冒药中的苯丙醇胺,是女性出血性中风的独立危险因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验